Ahmet Şenocak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmet Şenocak has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Bunyamin Cim
Fırat University Faculty of Medicine, Department of Obstetrics and Gynecology, Elazığ, Türkiye
5 shared publications - Salih Burcin Kavak
Department of Obstetrics and Gynecology, Faculty of Medicine, Firat University, Elazig 23119, Turkey
5 shared publications - Cengiz Şanlı
Department of Obstetrics and Gynecology, Turkish Ministry of Health Elazığ Fethi Sekin City Hospital, University of Health Sciences
4 shared publications - Ibrahim Batmaz
Department of Obstetrics and Gynecology, Faculty of Medicine, Mardin Artuklu University, Mardin, Turkey
4 shared publications - Mesut Ali Halisçelik
Health Sciences University, Gazi Yaşargil Training and Research Hospital, Turkey
4 shared publications - Cigdem Akcabay
Department of Obstetrics and Gynecology, Faculty of Medicine, Fırat University, Elazığ 23200, Türkiye
3 shared publications
Latest Publications
- Open Access
- 15 October 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (4) , 292-298
Comparison of asprosin immunoreactivity in endometrial hyperplasia and grade-1 endometrial adenocarcinoma: A retrospective case-control study
Comparison of asprosin immunoreactivity in endometrial hyperplasia and grade-1 endometrial adenocarcinoma: A retrospective case-control study - Turkish Journal of Obstetrics and Gynecology
- 15 October 2025
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 22 (4) , 292-298
Open AccessComparison of asprosin immunoreactivity in endometrial hyperplasia and grade-1 endometrial adenocarcinoma: A retrospective case-control study
Comparison of asprosin immunoreactivity in endometrial hyperplasia and grade-1 endometrial adenocarcinoma: A retrospective case-control study - Turkish Journal of Obstetrics and Gynecology
- Open Access
- 16 July 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 764
Evaluation of transcutaneous bilirubin levels in healthy and preeclamptic pregnancies: a pilot study
Preeclampsia is a complex, multisystem obstetric disorder characterized by heterogeneous clinical manifestations, often requiring enhanced strategies for early detection, management, and risk stratification. This study aimed to evaluate potential alterations in non-invasive transcutaneous bilirubin levels measured at various maternal body sites in pregnant women diagnosed with preeclampsia. A total of 86 pregnant women who delivered at our institution were enrolled and classified into three groups: healthy pregnant women (Group 1, n = 30), women with preeclampsia (Group 2, n = 30), and women with pre-eclampsia with severe features (Group 3, n = 26). In addition to routine pre-delivery laboratory assessments, transcutaneous bilirubin levels were measured at two anatomical sites—the forehead and the abdominal skin overlying the uterine fundus—using a standard bilirubinometer. Each site was measured three times, and the mean of the three readings was recorded for analysis. Complete Blood Count and biochemical blood parameters of the women were evaluated. Relevant obstetric and demographic data were also collected and recorded. There were no statistically significant differences among the three groups in terms of maternal age, gravidity, parity, or body mass index (p > 0.05). Similarly, total serum bilirubin levels were comparable across the groups (Group 1: 0.45 mg/dL; Group 2: 0.39 mg/dL; Group 3: 0.44 mg/dL; p > 0.05). In contrast, transcutaneous bilirubin levels were significantly elevated in Group 3 compared to Groups 1 and 2. The mean transcutaneous bilirubin values for the forehead, uterine fundus, and overall (combined sites) were as follows: Group 1—3.07 ± 0.85, 2.35 ± 0.97, and 2.71 ± 0.76; Group 2—6.09 ± 1.94, 4.94 ± 1.64, and 5.52 ± 1.59; Group 3—7.12 ± 1.81, 6.12 ± 2.25, and 6.63 ± 1.69, respectively. All pairwise comparisons demonstrated statistically significant differences (p < 0.05). Transcutaneous bilirubin levels were significantly elevated in women with preeclampsia, particularly among those with severe disease. As a non-invasive, rapid, and cost-effective approach, TcB measurement may function as an adjunctive tool for the initial clinical assessment and risk stratification of preeclamptic patients.
- 16 July 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 764
Open AccessEvaluation of transcutaneous bilirubin levels in healthy and preeclamptic pregnancies: a pilot study
Preeclampsia is a complex, multisystem obstetric disorder characterized by heterogeneous clinical manifestations, often requiring enhanced strategies for early detection, management, and risk stratification. This study aimed to evaluate potential alterations in non-invasive transcutaneous bilirubin levels measured at various maternal body sites in pregnant women diagnosed with preeclampsia. A total of 86 pregnant women who delivered at our institution were enrolled and classified into three groups: healthy pregnant women (Group 1, n = 30), women with preeclampsia (Group 2, n = 30), and women with pre-eclampsia with severe features (Group 3, n = 26). In addition to routine pre-delivery laboratory assessments, transcutaneous bilirubin levels were measured at two anatomical sites—the forehead and the abdominal skin overlying the uterine fundus—using a standard bilirubinometer. Each site was measured three times, and the mean of the three readings was recorded for analysis. Complete Blood Count and biochemical blood parameters of the women were evaluated. Relevant obstetric and demographic data were also collected and recorded. There were no statistically significant differences among the three groups in terms of maternal age, gravidity, parity, or body mass index (p > 0.05). Similarly, total serum bilirubin levels were comparable across the groups (Group 1: 0.45 mg/dL; Group 2: 0.39 mg/dL; Group 3: 0.44 mg/dL; p > 0.05). In contrast, transcutaneous bilirubin levels were significantly elevated in Group 3 compared to Groups 1 and 2. The mean transcutaneous bilirubin values for the forehead, uterine fundus, and overall (combined sites) were as follows: Group 1—3.07 ± 0.85, 2.35 ± 0.97, and 2.71 ± 0.76; Group 2—6.09 ± 1.94, 4.94 ± 1.64, and 5.52 ± 1.59; Group 3—7.12 ± 1.81, 6.12 ± 2.25, and 6.63 ± 1.69, respectively. All pairwise comparisons demonstrated statistically significant differences (p < 0.05). Transcutaneous bilirubin levels were significantly elevated in women with preeclampsia, particularly among those with severe disease. As a non-invasive, rapid, and cost-effective approach, TcB measurement may function as an adjunctive tool for the initial clinical assessment and risk stratification of preeclamptic patients.
- Open Access
The Role of Mid-Trimester BUN and Creatinine Assessment in Predicting Preeclampsia: Retrospective Case–Control Study
Background and Objectives: Preeclampsia (PE) is a major cause of adverse perinatal outcomes. Early diagnosis of pregnant women at risk of PE can facilitate disease prevention and management. However, the presence of different phenotypes of the disease complicates its prediction. In particular, the challenges in the early diagnosis of term PE cases necessitate research on PE prediction in the second and third trimesters. This study aims to examine the association between PE development and mid-trimester blood urea nitrogen (BUN), serum creatinine, and the BUN/creatinine ratio in pregnant women. Materials and Methods: This retrospective case–control study was conducted on women diagnosed with PE. Pregnant women who underwent routine biochemical blood tests between the 18th and 24th weeks of gestation and subsequently gave birth at our hospital between January 2022 and May 2023 were categorized into three groups. Accordingly, healthy women who had term deliveries were classified as Group 1 (150 cases), women diagnosed with PE were classified as Group 2 (58 cases), and those diagnosed with severe PE were classified as Group 3 (44 cases). Results: There were no significant differences in age, gravidity, parity, body mass index, or gestational week at blood sampling between the patient and control groups (p > 0.05). When comparing the mean blood urea nitrogen, serum creatinine, and BUN/creatinine ratios, a significant difference was observed between the control group and those who developed PE (p = 0.001, p < 0.001, and p = 0.031, respectively). Univariate analysis revealed a significant association between BUN levels and PE development (OR 1.083; 95% CI, 1.031–1.139; p = 0.002). A stronger association was observed between serum creatinine levels and PE development (OR 112.344; 95% CI, 11.649–1083.416; p < 0.001). However, no significant association was found between the BUN/creatinine ratio and PE in univariate analysis (OR 1.003; 95% CI, 0.979–1.028; p > 0.05). Mid-trimester BUN and serum creatinine levels were significantly higher in patients who developed PE and severe PE. The AUC value for the BUN parameter in predicting PE was 0.614 (AUC 0.614; 95% CI, 0.539–0.689; p = 0.002). A BUN cut-off value of 16.2 mg/dL predicted disease development with a sensitivity of 52.9% and a specificity of 74%. Similarly, the AUC value for the serum creatinine parameter in predicting PE was 0.644 (AUC 0.644; 95% CI, 0.574–0.751; p < 0.001). A serum creatinine cut-off value of 0.58 mg/dL was able to predict disease development with 37.2% sensitivity and 88% specificity. No significant AUC value was obtained for the BUN/creatinine ratio (p > 0.05). Conclusions: Our findings indicate that elevated BUN and serum creatinine levels measured during the mid-trimester (18–24 weeks) are associated with an increased risk of developing preeclampsia.
Open AccessThe Role of Mid-Trimester BUN and Creatinine Assessment in Predicting Preeclampsia: Retrospective Case–Control Study
Background and Objectives: Preeclampsia (PE) is a major cause of adverse perinatal outcomes. Early diagnosis of pregnant women at risk of PE can facilitate disease prevention and management. However, the presence of different phenotypes of the disease complicates its prediction. In particular, the challenges in the early diagnosis of term PE cases necessitate research on PE prediction in the second and third trimesters. This study aims to examine the association between PE development and mid-trimester blood urea nitrogen (BUN), serum creatinine, and the BUN/creatinine ratio in pregnant women. Materials and Methods: This retrospective case–control study was conducted on women diagnosed with PE. Pregnant women who underwent routine biochemical blood tests between the 18th and 24th weeks of gestation and subsequently gave birth at our hospital between January 2022 and May 2023 were categorized into three groups. Accordingly, healthy women who had term deliveries were classified as Group 1 (150 cases), women diagnosed with PE were classified as Group 2 (58 cases), and those diagnosed with severe PE were classified as Group 3 (44 cases). Results: There were no significant differences in age, gravidity, parity, body mass index, or gestational week at blood sampling between the patient and control groups (p > 0.05). When comparing the mean blood urea nitrogen, serum creatinine, and BUN/creatinine ratios, a significant difference was observed between the control group and those who developed PE (p = 0.001, p < 0.001, and p = 0.031, respectively). Univariate analysis revealed a significant association between BUN levels and PE development (OR 1.083; 95% CI, 1.031–1.139; p = 0.002). A stronger association was observed between serum creatinine levels and PE development (OR 112.344; 95% CI, 11.649–1083.416; p < 0.001). However, no significant association was found between the BUN/creatinine ratio and PE in univariate analysis (OR 1.003; 95% CI, 0.979–1.028; p > 0.05). Mid-trimester BUN and serum creatinine levels were significantly higher in patients who developed PE and severe PE. The AUC value for the BUN parameter in predicting PE was 0.614 (AUC 0.614; 95% CI, 0.539–0.689; p = 0.002). A BUN cut-off value of 16.2 mg/dL predicted disease development with a sensitivity of 52.9% and a specificity of 74%. Similarly, the AUC value for the serum creatinine parameter in predicting PE was 0.644 (AUC 0.644; 95% CI, 0.574–0.751; p < 0.001). A serum creatinine cut-off value of 0.58 mg/dL was able to predict disease development with 37.2% sensitivity and 88% specificity. No significant AUC value was obtained for the BUN/creatinine ratio (p > 0.05). Conclusions: Our findings indicate that elevated BUN and serum creatinine levels measured during the mid-trimester (18–24 weeks) are associated with an increased risk of developing preeclampsia.
- Open Access
- 17 March 2025
- Published by MDPI AG in Preprints.org
The Role of Mid-Trimester BUN and Creatinine Assessment in Predicting Preeclampsia: Retrospective Case-Control Study
Background and Objectives: Preeclampsia (PE) is a major cause of adverse perinatal outcomes. Early diagnosis of pregnant women at risk of PE can facilitate disease prevention and management. However, the presence of different phenotypes of the disease complicates its prediction. In particular, the challenges in the early diagnosis of term PE cases necessitate research on PE prediction in the second and third trimesters. This study aims to examine the association between PE development and mid-trimester blood urea nitrogen (BUN), serum creatinine, and the BUN/creatinine ratio in pregnant women. Materials and Methods: This retrospective case-control study was conducted on women diagnosed with PE. Pregnant women who underwent routine biochemical blood tests between the 18th and 24th weeks of gestation and subsequently gave birth at our hospital between January 2022 and May 2023 were categorized into three groups. Accordingly, healthy women who had term deliveries were classified as Group 1 (150 cases), women diagnosed with PE were classified as Group 2 (58 cases), and those diagnosed with severe PE were classified as Group 3 (44 cases). Results: There were no significant differences in age, gravidity, parity, body mass index, or gestational week at blood sampling between the patient and control groups (p > 0.05). When comparing the mean blood urea nitrogen, serum creatinine, and BUN/creatinine ratios, a significant difference was observed between the control group and those who developed PE (p = 0.001, p < 0.001, and p = 0.031, respectively). Univariate analysis revealed a significant association between BUN levels and PE development (OR 1.083; 95% CI, 1.031-1.139; p = 0.002). A stronger association was observed between serum creatinine levels and PE development (OR 112.344; 95% CI, 11.649-1083.416; p < 0.001). However, no significant association was found between the BUN/creatinine ratio and PE in univariate analysis (OR 1.003; 95% CI, 0.979-1.028; p > 0.05). Mid-trimester BUN and serum creatinine levels were significantly higher in patients who developed PE and severe PE. The AUC value for the BUN parameter in predicting PE was 0.614 (AUC 0.614; 95% CI, 0.539-0.689; p = 0.002). A BUN cut-off value of 16.2 mg/dL predicted disease development with a sensitivity of 52.9% and a specificity of 74%. Similarly, the AUC value for the serum creatinine parameter in predicting PE was 0.644 (AUC 0.644; 95% CI, 0.574-0.751; p < 0.001). A serum creatinine cut-off value of 0.58 mg/dL was able to predict disease development with 37.2% sensitivity and 88% specificity. No significant AUC value was obtained for the BUN/creatinine ratio (p > 0.05). Conclusions: There is a positive correlation between elevated mid-trimester BUN and serum creatinine levels and the subsequent development of preeclampsia syndrome.
- 17 March 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Role of Mid-Trimester BUN and Creatinine Assessment in Predicting Preeclampsia: Retrospective Case-Control Study
Background and Objectives: Preeclampsia (PE) is a major cause of adverse perinatal outcomes. Early diagnosis of pregnant women at risk of PE can facilitate disease prevention and management. However, the presence of different phenotypes of the disease complicates its prediction. In particular, the challenges in the early diagnosis of term PE cases necessitate research on PE prediction in the second and third trimesters. This study aims to examine the association between PE development and mid-trimester blood urea nitrogen (BUN), serum creatinine, and the BUN/creatinine ratio in pregnant women. Materials and Methods: This retrospective case-control study was conducted on women diagnosed with PE. Pregnant women who underwent routine biochemical blood tests between the 18th and 24th weeks of gestation and subsequently gave birth at our hospital between January 2022 and May 2023 were categorized into three groups. Accordingly, healthy women who had term deliveries were classified as Group 1 (150 cases), women diagnosed with PE were classified as Group 2 (58 cases), and those diagnosed with severe PE were classified as Group 3 (44 cases). Results: There were no significant differences in age, gravidity, parity, body mass index, or gestational week at blood sampling between the patient and control groups (p > 0.05). When comparing the mean blood urea nitrogen, serum creatinine, and BUN/creatinine ratios, a significant difference was observed between the control group and those who developed PE (p = 0.001, p < 0.001, and p = 0.031, respectively). Univariate analysis revealed a significant association between BUN levels and PE development (OR 1.083; 95% CI, 1.031-1.139; p = 0.002). A stronger association was observed between serum creatinine levels and PE development (OR 112.344; 95% CI, 11.649-1083.416; p < 0.001). However, no significant association was found between the BUN/creatinine ratio and PE in univariate analysis (OR 1.003; 95% CI, 0.979-1.028; p > 0.05). Mid-trimester BUN and serum creatinine levels were significantly higher in patients who developed PE and severe PE. The AUC value for the BUN parameter in predicting PE was 0.614 (AUC 0.614; 95% CI, 0.539-0.689; p = 0.002). A BUN cut-off value of 16.2 mg/dL predicted disease development with a sensitivity of 52.9% and a specificity of 74%. Similarly, the AUC value for the serum creatinine parameter in predicting PE was 0.644 (AUC 0.644; 95% CI, 0.574-0.751; p < 0.001). A serum creatinine cut-off value of 0.58 mg/dL was able to predict disease development with 37.2% sensitivity and 88% specificity. No significant AUC value was obtained for the BUN/creatinine ratio (p > 0.05). Conclusions: There is a positive correlation between elevated mid-trimester BUN and serum creatinine levels and the subsequent development of preeclampsia syndrome.
- Open Access
- 31 August 2024
- Published by Istanbul Gelisim University in İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi
- No. 23,p. 708-721
Deprem ve COVID-19 Salgınının Neden Olduğu Maternal Stresin Pre/eklampsi Üzerine Olan Etkisinin İncelenmesi
Amaç: 24 Ocak 2020 tarihinde Elazığ’da meydana gelen deprem ve 1 Nisan 2020’de Türkiye geneline yayılan COVID-19 salgınının pre/eklampsi spekturumu üzerine olan etkilerinin incelenmesi. Yöntem: Çalışma 1 Temmuz 2019 ile 1 Mart 2021 tarihleri arasında doğum için Fırat Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Kliniği’ne başvuran gebelerin dosyalarının retrospektif olarak incelenmesi yoluyla yapıldı. Grup 1’deki olgular 1 Temmuz 2019 – 1 Ocak 2020 tarihleri arasında doğum yapan gebelerin pre-eklampsi, HELLP sendromu ve süperempoze preeklampsi olanlar ve Grup 2’deki olgular 1 Eylül 2020 – 1 Mart 2021 tarihleri arasında aynı tanılara sahip olan gebelerin incelenmesi yoluyla belirlendi. Bulgular: 1 Temmuz 2019 – 1 Ocak 2020 tarihleri arasında (Grup 1) toplam 605 doğum gerçekleşti. 1 Eylül 2020 – 1 Mart 2021 tarihleri arasında (Grup 2) toplam 654 doğum gerçekleşti. Grup 1’de preeklampsi ve ilişkili hastalıkların insidansı %4,8 iken, Grup 2’de bu oran %7,5 olarak gerçekleşmiştir (değişim oranı +%56,2). Maternal stres sonrası sıklığı en fazla artan hastalık şiddetli preeklampsi (+%103,3) olmuştur. Sonuç: Çalışmada, maternal stresin preeklampsi ve ilişkili hastalıkların insidansını belirgin derecede arttırdığı tespit edilmiştir. Ağır strese neden olan olaylar sonrasında, sağlık hizmeti sunucularının hazırlıklı olması gerekmektedir.
- 31 August 2024
- Published by Istanbul Gelisim University in İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi
- No. 23,p. 708-721
Open AccessDeprem ve COVID-19 Salgınının Neden Olduğu Maternal Stresin Pre/eklampsi Üzerine Olan Etkisinin İncelenmesi
Amaç: 24 Ocak 2020 tarihinde Elazığ’da meydana gelen deprem ve 1 Nisan 2020’de Türkiye geneline yayılan COVID-19 salgınının pre/eklampsi spekturumu üzerine olan etkilerinin incelenmesi. Yöntem: Çalışma 1 Temmuz 2019 ile 1 Mart 2021 tarihleri arasında doğum için Fırat Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Kliniği’ne başvuran gebelerin dosyalarının retrospektif olarak incelenmesi yoluyla yapıldı. Grup 1’deki olgular 1 Temmuz 2019 – 1 Ocak 2020 tarihleri arasında doğum yapan gebelerin pre-eklampsi, HELLP sendromu ve süperempoze preeklampsi olanlar ve Grup 2’deki olgular 1 Eylül 2020 – 1 Mart 2021 tarihleri arasında aynı tanılara sahip olan gebelerin incelenmesi yoluyla belirlendi. Bulgular: 1 Temmuz 2019 – 1 Ocak 2020 tarihleri arasında (Grup 1) toplam 605 doğum gerçekleşti. 1 Eylül 2020 – 1 Mart 2021 tarihleri arasında (Grup 2) toplam 654 doğum gerçekleşti. Grup 1’de preeklampsi ve ilişkili hastalıkların insidansı %4,8 iken, Grup 2’de bu oran %7,5 olarak gerçekleşmiştir (değişim oranı +%56,2). Maternal stres sonrası sıklığı en fazla artan hastalık şiddetli preeklampsi (+%103,3) olmuştur. Sonuç: Çalışmada, maternal stresin preeklampsi ve ilişkili hastalıkların insidansını belirgin derecede arttırdığı tespit edilmiştir. Ağır strese neden olan olaylar sonrasında, sağlık hizmeti sunucularının hazırlıklı olması gerekmektedir.
- Open Access
- 1 January 2023
- Published by Turkiye Klinikleri in Journal of Clinical Obstetrics & Gynecology
- Vol. 33 (4) , 203-209
Comparison of the Effectiveness of Classical and Single-knot Fascia Closure Methods in Reducing Pain and Tenderness in the Incision Area After Cesarean Section: A Prospective Cohort Study
Objective: We compared the effects of single-knot fascia closure technique and classical fascia closure technique on postoperative pain in fascia closure. Material and Methods: In this prospective cohort study, 80 term non-obese pregnant women who had no complicated pregnancy and no additional disease, and who were planned for elective cesarean section were included in the study. Classical fascia closure method was applied to one group (n=40) and single-knot fascia closure method was applied to the other group (n=40). In the singleknot fascia closure technique, the suture was threaded down from the upper part of the right fascia corner and the needle was removed from the lower part of the fascia upwards, approximately 0.5 cm behind the left fascia corner. In the classical fascia closure technique, the fascia was closed continuously. Pain was evaluated with visual analogue scale (VAS) at 8th, 24th hours, and 3rd months postoperatively. The cases were followed up for the development of infection, hematoma, seroma, and hernia at the wound site within 3 months postoperatively. Results: Wound infection, seroma, hematoma, and hernia did not develop in the postoperative period in both groups. However, VAS values at the 8th and 24th hours and 3rd months were significantly lower in the group in which the single knot fascia closure method was applied. Conclusion: The single-knot fascia closure method is an effective and reliable method in reducing postoperative pain after cesarean section.
- 1 January 2023
- Published by Turkiye Klinikleri in Journal of Clinical Obstetrics & Gynecology
- Vol. 33 (4) , 203-209
Open AccessComparison of the Effectiveness of Classical and Single-knot Fascia Closure Methods in Reducing Pain and Tenderness in the Incision Area After Cesarean Section: A Prospective Cohort Study
Objective: We compared the effects of single-knot fascia closure technique and classical fascia closure technique on postoperative pain in fascia closure. Material and Methods: In this prospective cohort study, 80 term non-obese pregnant women who had no complicated pregnancy and no additional disease, and who were planned for elective cesarean section were included in the study. Classical fascia closure method was applied to one group (n=40) and single-knot fascia closure method was applied to the other group (n=40). In the singleknot fascia closure technique, the suture was threaded down from the upper part of the right fascia corner and the needle was removed from the lower part of the fascia upwards, approximately 0.5 cm behind the left fascia corner. In the classical fascia closure technique, the fascia was closed continuously. Pain was evaluated with visual analogue scale (VAS) at 8th, 24th hours, and 3rd months postoperatively. The cases were followed up for the development of infection, hematoma, seroma, and hernia at the wound site within 3 months postoperatively. Results: Wound infection, seroma, hematoma, and hernia did not develop in the postoperative period in both groups. However, VAS values at the 8th and 24th hours and 3rd months were significantly lower in the group in which the single knot fascia closure method was applied. Conclusion: The single-knot fascia closure method is an effective and reliable method in reducing postoperative pain after cesarean section.
- 2 November 2022
- Published by Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Dergisi in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
- Vol. 17 (3) , 30-35
Kadın Hastalıkları ve Doğum Kliniğinde Serebral Ven Sinüs Trombozu Gelişen Olguların Değerlendirilmesi: Retrospektif Çalışma
Özet Amaç: Serebral Ven Sinüs Trombozu (SVST) çok çeşitli ve nonspesifik semptomlarla kendini gösteren ve farklı etiyolojilere bağlı olarak ortaya çıkan klinik bir durumdur. Tanısı kolayca konulamayan nadir bir hastalıktır. Biz bu yazıda SVST gelişen olgularda, jinekolojik ve obstetrik nedenlerin araştırılmasını amaçladık. Gereç ve Yöntemler: Fırat Üniversitesi Tıp Fakültesi Hastanesi’ne Kasım 2010 ile Kasım 2020 tarihleri arasında nörolojik şikayetlerle başvuran, yapılan değerlendirmede SVST tanısı konulan olgular ile obstetrik/jinekolojik nedenlerle SVST gelişen kadınlar, retrospektif olarak incelendi. Kadınların başvuru şikâyetleri, nöroradyolojik bulguları ve uygulanan tedaviler kayıtlardan tespit edildi. Verilerin değerlendirmesinde tanımlayıcı istatistik kullanıldı. Bulgular: Çalışmanın yapıldığı dönemde 166 olguya SVST tanısı konuldu. Olguların 105’i kadın (%63.2) ve 61’i erkek (%36.8) idi. On beş olguda (% 9) obstetrik ve jinekolojik nedenlere sekonder SVST geliştiği tespit edildi. En sık semptom baş ağrısı (%80) ve en sık bulgu papil ödemi (%20) ile birlikte hemiparezi (%13.3) ve hemipleji (%6.7) olarak tespit edildi. Çalışmaya dâhil edilen altı olgu (%40) puerperal dönemde idi. Bunlardan iki olgu (%13.3) vajinal yolla, dört olgu (%26.7) ise sezaryenle doğum yapmıştı. Olgulardan beş tanesi (%33.3) gebe idi. Gebelerin tamamı gebeliğin 3. trimesterinde bulunuyordu. Bir olguda (%6.7) mastoidit geliştiği ve 4 ay öncesinde vajinal yolla doğum yaptığı tespit edildi. Bir olgunun puerperal dönemde olduğu ve eşlik eden sinüzit enfeksiyonu bulunduğu (%6.7), ayrıca aile öyküsünde postpartum derin ven trombozu varlığı tespit edildi. İki olgunun (%13.3) kombine oral kontraseptif (OKS) kullandığı, bunlardan birinde MTHFR homozigot mutasyon varlığı ve homosistein yüksekliği olduğu tespit edildi. Olguların tamamı değerlendirildiğinde 7 olguda (%4.2) kalıtsal trombofili tanısı mevcuttu. Sonuç: SVST olgularında gebelik, puerperal dönem ve OKS kullanımı başta olmak üzere, obstetrik ve jinekolojik nedenler %10’a yakın yer tutar ve değerlendirme sırasında göz önünde bulundurulmalıdır
- 2 November 2022
- Published by Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Dergisi in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
- Vol. 17 (3) , 30-35
Kadın Hastalıkları ve Doğum Kliniğinde Serebral Ven Sinüs Trombozu Gelişen Olguların Değerlendirilmesi: Retrospektif Çalışma
Özet Amaç: Serebral Ven Sinüs Trombozu (SVST) çok çeşitli ve nonspesifik semptomlarla kendini gösteren ve farklı etiyolojilere bağlı olarak ortaya çıkan klinik bir durumdur. Tanısı kolayca konulamayan nadir bir hastalıktır. Biz bu yazıda SVST gelişen olgularda, jinekolojik ve obstetrik nedenlerin araştırılmasını amaçladık. Gereç ve Yöntemler: Fırat Üniversitesi Tıp Fakültesi Hastanesi’ne Kasım 2010 ile Kasım 2020 tarihleri arasında nörolojik şikayetlerle başvuran, yapılan değerlendirmede SVST tanısı konulan olgular ile obstetrik/jinekolojik nedenlerle SVST gelişen kadınlar, retrospektif olarak incelendi. Kadınların başvuru şikâyetleri, nöroradyolojik bulguları ve uygulanan tedaviler kayıtlardan tespit edildi. Verilerin değerlendirmesinde tanımlayıcı istatistik kullanıldı. Bulgular: Çalışmanın yapıldığı dönemde 166 olguya SVST tanısı konuldu. Olguların 105’i kadın (%63.2) ve 61’i erkek (%36.8) idi. On beş olguda (% 9) obstetrik ve jinekolojik nedenlere sekonder SVST geliştiği tespit edildi. En sık semptom baş ağrısı (%80) ve en sık bulgu papil ödemi (%20) ile birlikte hemiparezi (%13.3) ve hemipleji (%6.7) olarak tespit edildi. Çalışmaya dâhil edilen altı olgu (%40) puerperal dönemde idi. Bunlardan iki olgu (%13.3) vajinal yolla, dört olgu (%26.7) ise sezaryenle doğum yapmıştı. Olgulardan beş tanesi (%33.3) gebe idi. Gebelerin tamamı gebeliğin 3. trimesterinde bulunuyordu. Bir olguda (%6.7) mastoidit geliştiği ve 4 ay öncesinde vajinal yolla doğum yaptığı tespit edildi. Bir olgunun puerperal dönemde olduğu ve eşlik eden sinüzit enfeksiyonu bulunduğu (%6.7), ayrıca aile öyküsünde postpartum derin ven trombozu varlığı tespit edildi. İki olgunun (%13.3) kombine oral kontraseptif (OKS) kullandığı, bunlardan birinde MTHFR homozigot mutasyon varlığı ve homosistein yüksekliği olduğu tespit edildi. Olguların tamamı değerlendirildiğinde 7 olguda (%4.2) kalıtsal trombofili tanısı mevcuttu. Sonuç: SVST olgularında gebelik, puerperal dönem ve OKS kullanımı başta olmak üzere, obstetrik ve jinekolojik nedenler %10’a yakın yer tutar ve değerlendirme sırasında göz önünde bulundurulmalıdır